Insider · CIK 0001890784

Anand Bhaskar

Reports to the SEC for 2 companies · MIAMI, FL

sec.gov

Transactions

Companies

Filings

CIK

0001890784

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-08	SMMTSummit Therapeutics Inc.A Award	Chief Accounting Officer	AAward	+100K sh	—	—	261,047
2026-01-08	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+30K sh	—	—	30,000
2025-10-21	SMMTSummit Therapeutics Inc.A Award	Chief Accounting Officer	AAward	+26.7K sh	$18.74	+$500K	159,751
2025-09-18	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+50K sh	—	—	50,000
2025-04-29	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+600K sh	—	—	600,000
2025-04-29	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+75K sh	—	—	75,000
2025-01-12	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+75K sh	—	—	75,000
2024-09-11	SMMTSummit Therapeutics Inc.A Award	Chief Accounting Officer	AAward	+22K sh	$22.70	+$500K	131,426
2024-04-02	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+600K sh	—	—	600,000
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP, Chief Accounting Officer	DDisposition to Issuer	−6,000 sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCD Disposition to Issuer	SVP, Chief Accounting Officer	DDisposition to Issuer	−24.1K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP, Chief Accounting Officer	DDisposition to Issuer	−15K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP, Chief Accounting Officer	DDisposition to Issuer	−23.4K sh	—	—	0
2023-09-26	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	SVP, Chief Accounting Officer	DDisposition to Issuer	−33.5K sh	—	—	0
2023-09-05	REATA PHARMACEUTICALS INCS Sale	SVP, Chief Accounting Officer	SSale	−406 sh	$169.20	−$68.7K	24,089
2023-08-16	REATA PHARMACEUTICALS INCS Sale	SVP, Chief Accounting Officer	SSale	−210 sh	$168.42	−$35.4K	24,495
2023-08-15	REATA PHARMACEUTICALS INCS Sale	SVP, Chief Accounting Officer	SSale	−193 sh	$169.06	−$32.6K	24,705
2023-06-14	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−1,562 sh	—	—	23,438
2023-06-14	REATA PHARMACEUTICALS INCM Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+1,562 sh	$27.32	+$42.7K	27,241
2023-06-14	REATA PHARMACEUTICALS INCS Sale	SVP, Chief Accounting Officer	SSale	−2,343 sh	$102.11	−$239K	24,898
2023-05-16	REATA PHARMACEUTICALS INCS Sale	SVP, Chief Accounting Officer	SSale	−136 sh	$81.10	−$11K	25,679
2023-05-15	REATA PHARMACEUTICALS INCS Sale	SVP, Chief Accounting Officer	SSale	−950 sh	$85.98	−$81.7K	25,815
2023-03-07	REATA PHARMACEUTICALS INCS Sale	SVP, Chief Accounting Officer	SSale	−165 sh	$84.58	−$14K	26,765
2023-03-03	REATA PHARMACEUTICALS INCS Sale	SVP, Chief Accounting Officer	SSale	−820 sh	$87.47	−$71.7K	26,930
2023-03-01	REATA PHARMACEUTICALS INCEmployee Stock Option (right-to-buy)A Award	SVP, Chief Accounting Officer	AAward	+6,000 sh	—	—	6,000
2023-03-01	REATA PHARMACEUTICALS INCA Award	SVP, Chief Accounting Officer	AAward	+3,000 sh	—	—	27,750
2023-01-03	REATA PHARMACEUTICALS INCA Award	SVP, Chief Accounting Officer	AAward	+8,250 sh	—	—	24,750
2023-01-03	REATA PHARMACEUTICALS INCEmployee Stock Option (right-to-buy)A Award	SVP, Chief Accounting Officer	AAward	+33.5K sh	—	—	33,500
2022-01-03	REATA PHARMACEUTICALS INCA Award	SVP, Chief Accounting Officer	AAward	+12.5K sh	—	—	16,500
2022-01-03	REATA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	SVP, Chief Accounting Officer	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Oct 14 16:074
Anand Bhaskar0001890784-26-000006
SEC(opens sec.gov)
Jan 124
Anand Bhaskar0001890784-26-000003
SEC(opens sec.gov)
Oct 234
Anand Bhaskar0001890784-25-000005
SEC(opens sec.gov)
Sep 194
Anand Bhaskar0001890784-25-000003
SEC(opens sec.gov)
May 14
Anand Bhaskar0001599298-25-000097
SEC(opens sec.gov)
Jan 144
Anand Bhaskar0001599298-25-000036
SEC(opens sec.gov)
Sep 134
Anand Bhaskar0001599298-24-000135
SEC(opens sec.gov)
Apr 44
Anand Bhaskar0001599298-24-000058
SEC(opens sec.gov)
Sep 264
Anand Bhaskar0000899243-23-019532
SEC(opens sec.gov)
Sep 74
Anand Bhaskar0001209191-23-048601
SEC(opens sec.gov)
Aug 174
Anand Bhaskar0001209191-23-046276
SEC(opens sec.gov)
Jun 164
Anand Bhaskar0001209191-23-037802
SEC(opens sec.gov)

Companies

Address

C/O SUMMIT THERAPEUTICS INC. 601 BRICKELL KEY DRIVE, SUITE 1000

MIAMI, FL, 33131